Roche reports positive data from Phase I obesity treatment trial

Roche reports positive data from Phase I obesity treatment trial

Source: 
Clinical Trials Arena
snippet: 

Roche has reported positive topline data from the ongoing multi-part Phase I clinical trial of CT-996, an oral GLP-1 receptor agonist, to treat type 2 diabetes (T2D) and obesity.